CYTOMED THERAPEUTICS LIMITED
Q4 2023 13F Holders
Symbol
GDTC
CUSIP
Y1R80M106
Type
Equity
Class
SHS
Num filers
3
Total reported value, excl. options
$21.5k
Compare 2023 Q4 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q3
2023 Q2
Manager
Report Date
Value ($000)
Shares
Option Type